News | June 14, 2007

Molecular Imaging of Diabetes Selected as 2007 Small Animal Image of the Year

June 15, 2007 - Avid Radiopharmaceuticals Inc. announced that a preclinical study presented at at the Society of Nuclear Medicine (SNM) Annual Meeting was selected as the 2007 Small Animal Image of the Year, showing a Positron Emission Tomography (PET) image of a rat pancreas following injection with AV-133, a molecular imaging agent.

The image highlighted the presentation entitled: “F-18 FP-DTBZ: An Investigational PET Ligand for Measuring Beta Cell Mass in the Pancreas,” with Drs. Mei-Ping Kung and Hank Kung as primary investigators. This study showed that AV-133, targeting the vesicular monoamine transporter-2 (VMAT2), is potentially useful for measurement of beta cell mass and for studying the pathogenesis of diabetes.

Declines in the number of beta cells in the pancreas are evident prior to the onset of diabetes and may be a useful early marker for increased risk of developing Type I or Type II diabetes. The amount of vesicular monoamine transporter (VMAT2), which is expressed by the beta cells of the pancreas, may reflect beta cell mass. Molecular imaging of beta cells using a VMAT2-targeted compound has the potential to detect losses in beta cells before a diagnosis of diabetes is possible by current methods. This may make it possible to identify individuals who are at elevated risk of developing diabetes to receive earlier treatment, and allow for monitoring of new treatments designed to preserve beta cells.

There are 20.8 million children and adults with diabetes in the United States alone (7 percent of the population). Diabetes mellitus (DM) is on the rise globally and is associated with an increased risk for serious, life-threatening complications including heart disease and stroke. Proactive disease control can help reduce risk; however, many people are not aware that they are at risk of diabetes until they develop one of its complications.

For more information: www.avidrp.com

Related Content

Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging | July 07, 2017
July 7, 2017 — Blood clots in veins a

While subject No. 1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in subject No. 2 (right). Image courtesy of Henryk Barthel et al., University Hospital Leipzig, Leipzig, Germany

News | PET Imaging | June 14, 2017
More people die of Alzheimer's disease than prostate and breast cancer combined. Identifying the disease before major...
News | Clinical Study | June 09, 2017
The milestone Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study is working with government and academic...
Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18
News | Radiopharmaceuticals and Tracers | May 22, 2017
May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced t
low-dose lung CT scan

An example of a low-dose CT scan of the lungs, showing lung cancer. Image courtesy of Toshiba.

Feature | Lung Cancer | May 05, 2017 | Alison Grimes
The term mesothelioma was coined in 1909, just a few years after the introduction of medical X-ray imaging.
Australian Team Finds New Method for Producing PET Radiotracers in Higher Radiochemical Yields
News | Radiopharmaceuticals and Tracers | April 28, 2017
April 28, 2017 — Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the devel
Sponsored Content | Videos | Nuclear Imaging | April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American S
News | Prostate Cancer | April 24, 2017
April 24, 2017 — Cancer Targeted Technology recently announced it is focusing on small molecules that target pivotal
PET
Feature | Imaging | April 11, 2017 | By Greg Freiherr
Positron emission tomography (PET) and other brain assessments
Overlay Init